Organogenesis Holdings Inc. (ORGO) financial statements and ratios from SEC XBRL: revenue $564.17M (TTM), net margin 6.6%, revenue growth 17.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $564.17M |
| Net Margin | 6.6% |
| Revenue Growth (YoY) | 17.0% |
| EPS Growth (YoY) | -1700.0% |
| FCF Growth (YoY) | -685.7% |
| Price / Book | 1.56 |
| Price / Sales | 0.86 |
| FCF Yield | -16.4% |
| DCF Value (model) | $4.39 |
| DCF Upside vs Price | 143.9% |
| Altman Z-Score | 2.17 (grey) |
| Sector P/E (Healthcare) | 21.7 |
ORGO overview · ORGO earnings · ORGO KPIs · ORGO investor relations · ORGO ownership · ORGO peers · ORGO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.